glycyl-glycyl-glycine has been researched along with Carcinoma, Hepatocellular in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gong, Y; Jian, X; Liu, X; Wang, T; Wu, X; Yao, Z; Zhang, Q; Zhao, J | 1 |
1 other study(ies) available for glycyl-glycyl-glycine and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Targeting PEPT1: a novel strategy to improve the antitumor efficacy of doxorubicin in human hepatocellular carcinoma therapy.
Topics: Animals; Biological Transport; Caco-2 Cells; Carcinoma, Hepatocellular; Cell Line, Tumor; Doxorubicin; Drug Synergism; Hep G2 Cells; Humans; Liver Neoplasms; Mice; Mice, Nude; Oligopeptides; Peptide Transporter 1; Symporters; Xenograft Model Antitumor Assays | 2017 |